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Abstract
The transport activity of the purified and reconstituted ornithine/citrulline carrier from rat liver mitochondria was correlated to
modification of its sulfhydryl groups by various reagents. Both the ornithine/ornithine (antiport) and the ornithine/H+ (unidirectional)
transport modes catalysed by the ornithine/citrulline carrier were inhibited by methanethiosulfonates, mercurial reagents, N-ethylmaleimide
(NEM) and 5,5V-dithiobis(2-nitrobenzoate) (DTNB). The treatment of the ornithine/citrulline carrier with mercurial reagents, at
concentrations above 5 AM, caused the induction of an additional (pore-like) transport mode, characterized by loss of substrate specificity
and a transport activity higher than that of the unmodified carrier. The S–S forming reagent Cu2 +-phenanthroline inhibited the transport
catalysed by the carrier, indicating the presence of close sulfhydryl groups. The effect of consecutive addition of the various reagents revealed
a peculiar aspect of the ornithine/citrulline carrier, i.e. the presence of three distinct populations of sulfhydryl groups. The first was
responsible for the inhibition of the physiological transport modes by methanethiosulfonates, NEM and DTNB and low concentrations ( < 5
AM) of mercurials; the second population was responsible for the transition to the pore-like activity induced by higher concentrations (>5
AM) of mercurials; the third population was involved in S–S bridge formation.
D 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
The ornithine/citrulline carrier is a metabolite transport
protein of the inner mitochondrial membrane. After prelimi-
nary studies on the ornithine and citrulline transport [1–7],
performed with intact mitochondria, the existence of this
carrier was definitively demonstrated by the identification of
a 33.5-kDa (on SDS-PAGE) protein that catalysed ornithine/
ornithine and ornithine/citrulline antiport when reconstituted
into liposomes [8]. More recently, the amino acid sequences
of the yeast ARG-11 [9] and the human ORNT1 [10]
ornithine carriers have been identified. Both the yeast and
the mammalian proteins show the structural properties of the
mitochondrial carrier family [11].
The mammalian ornithine/citrulline carrier plays an im-
portant role in the urea cycle as it was proposed by functional
studies in intact mitochondria and in reconstituted liposomes
[4,8,12,13] and confirmed by the finding that deficiency of
ORNT1 gene lead to HHH syndrome [10] and that the
hormonal regulation of the ORNT1 expression in liver is
integrated with that of the urea cycle enzymes [14].
The ornithine/citrulline antiport catalysed by this carrier
has been extensively characterized in reconstituted lipo-
somes. It is electroneutral since the positive charge of
ornithine is compensated by a H+ co-transported with citrul-
line [13]. The half-saturation constant of the carrier for
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ornithine on the external side is about 20 times lower than
that on the internal side [15]; on the contrary, the half-
saturation constants for citrulline on the external and inter-
nal side are comparable. The asymmetry of the carrier in the
mitochondrial membrane should facilitate channeling of the
urea cycle substrates among the enzymes and the transport
system [15–17]. The substrate antiport (ornithine/ornithine
and ornithine/citrulline) catalysed by the ornithine/citrulline
carrier follows a simultaneous (sequential) transport mech-
anism [15] as all but one of the mitochondrial carriers
characterized so far [11].
A further role for the ornithine/citrulline carrier has been
proposed on the basis of functional studies in intact mito-
chondria [3] and in reconstituted liposomes [18]: the carrier
catalyses unidirectional transport of ornithine which should
be important for arginine catabolism and polyamine biosyn-
thesis. This second transport mode is active in the absence
of countersubstrate and is electroneutral since a H+ is
transported in exchange with ornithine (ornithine/H+
exchange). Ornithine/H+ transport rate under optimal con-
dition is about one third of the maximal ornithine/citrulline
antiport rate.
To clarify the relationships between structure and func-
tion of this metabolically important transport system, further
studies on the role of specific amino acid residues are
required. Both the human and the mouse ornithine carriers
contain nine Cys residues [10]; nevertheless, the sensitivity
of the ornithine/citrulline carrier to SH reagents is still
unclear. In studies performed with intact mitochondria, it
was reported that N-ethylmaleimide (NEM) inhibited orni-
thine transport whereas mersalyl had no effect [5]. Later on,
in studies performed with the reconstituted carrier, it was
found that mercurial reagents and maleimides inhibited to
different extent the ornithine/ornithine antiport [8].
In this paper, we have performed a detailed study on the
effect of chemical modification of Cys of the ornithine/
citrulline carrier, which provided new information on the
role of SH groups on the transport function. Using SH
reagents with different properties, we could discriminate
three populations of SH groups. Two of them are function-
ally involved in the translocation pathway of the reconsti-
tuted ornithine/citrulline carrier. A further population is
responsible for the induction of an additional transport mode
that is characterized by loss of specificity for substrate,
similarly to the pore-like activity described for the aspartate/
glutamate [19,20], the adenine nucleotide [19], the carnitine
[21] and the phosphate [22] carriers of mitochondria.
2. Materials and methods
2.1. Materials
Hydroxyapatite (Bio-Gel HTP) and Bio-Beads SM-2
were purchased from Bio-Rad; Celite 535 from Roth;
DEAE-Sephacel, Sephadex PD-10, Sephadex G-50 and G-
75 from Pharmacia; L-[2,3-3H]ornithine, egg yolk phospho-
lipids (L-a-phosphatidylcholine from fresh turkey egg yolk),
HEPES and Triton X-100 from Sigma; (2-aminoethyl)me-
thanethiosulfonate hydrobromide (MTSEA), [2-(trimethy-
lammonium)ethyl]methanethiosulfonate (MTSET) and
sodium(2-sulfonatoethyl)methanethiosulfonate (MTSES)
were from Toronto Research Chemicals (North York,
Ontario, Canada). All other reagents were of analytical
grade.
2.2. Purification and reconstitution of the ornithine/citrul-
line carrier
The ornithine/citrulline carrier was purified from rat liver
mitochondria as previously described [8]. The purified
protein was reconstituted into liposomes by removing the
detergent with a hydrophobic column [23,24]. In this
procedure, the mixed micelles containing detergent, protein
and phospholipids were repeatedly passed through a column
filled with Bio-Beads SM-2 resin. The composition of the
initial mixture used for reconstitution was 400 Al of purified
protein in 3% Triton X-100 (Celite eluate, about 1 Ag
protein), 100 Al of 10% egg yolk phospholipids in the form
of sonicated liposomes prepared as described previously
[25], 30 mM L-ornithine (unless otherwise indicated) and 20
mM HEPES pH 8.0 in a final volume of 700 Al. After
vortexing, this mixture was passed 14 times through the
same Bio-Beads SM-2 column (0.5 3.2 cm), preequili-
brated with the same buffer and substrate present in the
initial mixture. All the operations were performed at 4 jC,
except the passages through Bio-Beads SM-2 column that
were performed at room temperature.
2.3. Transport measurements
The external substrate was removed by passing 550 Al of
proteoliposomes through a Sephadex G-75 column (0.7 15
cm) preequilibrated with 10 mM HEPES pH 8.0 (unless
otherwise indicated) and 60 mM sucrose to balance the
internal osmolarity. The first 600 Al of the turbid eluate from
the Sephadex column were collected, transferred to reac-
tion vessels (100 Al each), and readily used for transport
measurements by the inhibitor-stop method [26]. For
uptake measurements, transport was initiated by adding
10 Al of [3H]ornithine at the final concentration of 0.1
mM. After the required time interval, the reaction was
stopped by adding 20 mM pyridoxal 5-phosphate/1 mM
NEM. In control samples, the inhibitor was added together
with the labeled substrate at time zero. The assay temperature
was 25 jC. The external radioactivity was removed by
passing the samples (100 Al) through a Sephadex G-50
column (0.6 8 cm). The liposomes eluted with 1.2 ml of
40 mM NaCl were collected in 4 ml of scintillation mixture,
vortexed and counted. The experimental values were cor-
rected by subtracting the respective control values. The
transport rate was evaluated from the radioactivity taken
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up by the proteoliposomes in 2 min, i.e. within the initial
linear range of substrate uptake.
For efflux measurements, the proteoliposomes containing
30 mM ornithine were prelabeled by carrier-mediated
exchange equilibration before starting the transport assay
[23]. This was achieved by incubating the proteoliposomes
(600 Al), passed through Sephadex G-75 in order to remove
the external substrate (see above), with 10 Al of 0.3 mM
[3H]ornithine at high specific radioactivity (3 ACi/nmol) for
20 min at 25 jC. Then, the external radioactivity was
removed by passing again the proteoliposomes through
Sephadex G-75 as described above except that this chroma-
tography was performed at 0 jC to minimize the loss of
internal substrate during the chromatography. Transport was
started by adding unlabeled external ornithine (ornithine/
ornithine antiport) or buffer alone (ornithine/H+ exchange)
at the concentration indicated in the legends to tables and
figures and stopped, at the appropriate time interval, as
described above. In the samples treated with p-hydroxymer-
curibenzoate ( p-OHMB) or p-chloromercuribenzenesulfo-
nate ( p-CMBS) (>5 AM), where NEM was no more
effective, the start time was defined as the time of addition
of the reagent or buffer alone; the elution on the Sephadex
G-50 columns was performed within 1 min at 0 jC in order
to minimize the efflux of labeled substrate during the
chromatography. Efflux activity was expressed as intra-
liposomal cpm. Initial rate of efflux (reported as cpm/min)
was obtained from time courses by fitting the experimental
data in a single exponential decay equation from which the
efflux rate was calculated as the product of k (the first order
rate constant) and A (the radioactivity effluxed from pro-
teoliposomes at infinite time) [23].
2.4. Other methods
The protein was determined by the Lowry method,
modified for the presence of nonionic detergents [27].
3. Results
3.1. Effect of SH reagents on ornithine/ornithine antiport
The inhibition of the ornithine/ornithine antiport cata-
lysed by the reconstituted ornithine/citrulline carrier by SH
reagents of different type was analysed as concentration
dependence; data are reported as semilogarithmic plots (Fig.
1). All the reagents tested lead to complete inhibition of
transport, even though with different efficiency. Among the
methanethiosolfonates (MTS), the most effective inhibitor
was MTSEA (IC50, 0.17F 0.03 AM) followed by MTSET
(IC50, 0.42F 0.08 AM) and (not shown) MTSES (IC50,
200F 39 AM). The most effective mercurial reagents were
p-OHMB (IC50, 0.59F 0.06 AM) and p-CMBS (IC50,
0.61F 0.05 AM) followed by mersalyl (IC50, 1.1F 0.11
AM) and (not shown) HgCl2 (IC50, 1.4F 0.21 AM). NEM
and 5,5V-dithiobis(2-nitrobenzoate) (DTNB) exhibited IC50
of 0.16F 0.02 and 1.45F 0.06 mM, respectively. After
complete inactivation by MTSEA, p-OHMB, p-CMBS
and DTNB, the protein could be reactivated by treatment
with 1.4-dithioerythritol (DTE). On the contrary, after treat-
ment with NEM, the addition of DTE did not restore the
transport activity (Table 1). Taking advantage by the differ-
ence in reactivity of NEM (irreversible) and other reagents
(reversible), we have investigated whether the various
reagents bind to the same or to different SH groups.
Proteoliposomes were first incubated with reversible
reagents and then NEM was added; after incubation, ali-
quots of the samples were treated with DTE. As shown by
Table 1, in the samples treated with reversible inhibitors
before NEM, a substantial recovery of activity was observed
upon addition of DTE, indicating a more or less extensive
protection of NEM inhibition by the reagents. Recovery
(protection) ranged from about 50% to 80% depending on
the reagent used for preincubation. This means that rever-
sible reagents and NEM react mainly with the same SH
groups; however, a fraction of about 20%, 30% or 50% of
the protein can still bind NEM, in the presence of MTSEA,
DTNB or mercurials, respectively.
3.2. Effect of SH reagents on the ornithine/H+ transport
mode and induction of a pore-like transport mode
In order to investigate the effect of SH reagents on the
alternative (ornithine/H+) transport mode of the ornithine/
citrulline carrier [18], we used the efflux procedure, which is
more effective for the detection of unidirectional flux of
Fig. 1. Dose– response curves for the inhibition of the reconstituted
ornithine/ornithine antiport by SH reagents. Proteoliposomes were
incubated with the inhibitors for 2 min. Then, ornithine/ornithine antiport
was measured by adding 0.1 mM [3H]ornithine and stopped after 2 min, as
described in Materials and methods. (E) NEM, (o) DTNB, (n) mersalyl,
(q) p-OHMB, (D) p-CMBS, (.) MTSEA, (5) MTSET. Percent residual
activity with respect to the control are reported. The control activity
(uninhibited ornithine/ornithine antiport) was 0.53F 0.15 mmol/2 min g
protein; the values are meansF S.D. from three experiments.
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substrate [23]. Fig. 2 describes the effect of SH reagents on
[3H]ornithine efflux from preloaded proteoliposomes in the
absence of external substrate (ornithine/H+ transport mode)
and, as control, in the presence of external ornithine
(ornithine/ornithine transport mode). In agreement with the
data reported in Fig. 1, 4 AM MTSEA, 4 AM p-OHMB or 1
mM NEM strongly inhibited the ornithine/ornithine anti-
port. Ornithine/H+ transport mode was also inhibited by
MTSEA and NEM, but it was not affected by the presence
of 4 AM p-OHMB or (not shown) 4 AM p-CMBS or 4 AM
mersalyl. DTNB (6.5 mM) showed a behaviour similar to
that of MTSEA (not shown). In order to gain further insight
on the lack of inhibition of the ornithine/H+ transport mode
by mercurials, the effect of various concentrations of p-
OHMB (0.1–100 AM) was studied (Fig. 3). The ornithine/
H+ efflux was inhibited in a concentration-dependent man-
ner at 0.1 and 0.3 AM. At higher concentration of p-OHMB,
the efflux of labeled ornithine increased again, being clearly
stimulated at concentrations above 5 AM. At 100 AM p-
OHMB, the efflux rate of [3H]ornithine (first-order rate
constant, k, 0.28) was much higher than the basic efflux
(ornithine/H+ transport mode; k, 0.006) and it was also
higher than the rate of the ornithine/ornithine antiport
(Fig. 2; k, 0.17). After the inactivation of the carrier by
incubation of the proteoliposomes with trypsin, the p-
OHMB-induced efflux was virtually abolished (Fig. 3),
indicating that the process is protein mediated. p-OHMB
induced a fast efflux of labeled ornithine with a mechanism
different from both the ornithine/ornithine antiport and
ornithine/H+ exchange presumably due to a transition of
the reconstituted translocator to a pore-like function. A
similar phenomenon was previously observed for other
Table 1
Protection by sulfhydryl reagents against NEM inhibition of the
reconstituted ornithine/citrulline carrier
Additions at
0 min 2 min 10 min Percent residual
activity
– – – 100
– – DTE 108F 4.0
MTSEA – – 5F 3
MTSEA – DTE 100F 4.7
p-OHMB – – 6F 4
p-OHMB – DTE 106F 16
p-CMBS – – 7F 4
p-CMBS – DTE 103F 14
DTNB – – 8F 7
DTNB – DTE 101F 3.4
NEM – – 2F 1
NEM – DTE 11F 3
MTSEA NEM – 5F 3
MTSEA NEM DTE 81F12
p-OHMB NEM – 2F 1
p-OHMB NEM DTE 47F 5
p-CMBS NEM – 4F 2
p-CMBS NEM DTE 53F 7
DTNB NEM – 7F 4
DTNB NEM DTE 69F 14
Proteoliposomes were incubated with different sulfhydryl reagents and
DTE was added at the time indicated. After a total incubation time of 20
min, ornithine/ornithine antiport was measured in all the samples by adding
0.1 mM [3H]ornithine and stopping the reaction at 10 min, as described in
Materials and methods. Reagents were used at the following concentrations:
5 AM p-OHMB, 5 AM p-CMBS, 10 mM DTNB, 2 AM MTSEA, 1 mM
NEM, 5 mM DTE. Percent residual activity was calculated for each
experiment with respect to its control sample (referred as 100%); the values
are meansF S.D. of the percentages for three experiments. The average
specific activity of the control samples of the three experiments analysed
was 1.80F 0.54 mmol/10 min/g protein.
Fig. 2. Effect of SH reagents on the ornithine/H+ transport mode. Efflux of
30 mM [3H]ornithine from prelabeled proteoliposomes was monitored, as
described in Materials and methods, in the presence of external buffer alone
(10 mM HEPES pH 8.0, 60 mM sucrose; ornithine/H+ exchange, open
symbols) or in the presence of 10 mM external ornithine (in a buffer
containing 10 mM HEPES pH 8.0, 40 mM sucrose; ornithine/ornithine
antiport, solid symbols). Inhibitors were added to the proteoliposomes 2
min before the start of the efflux: (D andE) 4 AM p-OHMB; (5 and n) 1
mM NEM; (q and z) 4 AM MTSEA; (o and .) controls without
inhibitor. Similar results were obtained in four different experiments.
Fig. 3. Dependence of [3H]ornithine efflux from proteoliposomes on p-
OHMB concentration. Efflux of 30 mM [3H]ornithine was measured in the
presence of external 10 mM HEPES pH 8, 60 mM sucrose (ornithine/H+
exchange): (5) no addition; (.) 0.1 AM, (q) 0.3 AM, (E) 0.7 AM, (o) 1
AM, ( w ) 5 AM, (n) 10 AM and (D) 100 AM p-OHMB. (y) 100 AM p-
OHMB was added to proteoliposomes preincubated with 0.3 mg/ml trypsin
for 15 min. Similar results were obtained in four different experiments.
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mitochondrial carriers [19–22]; it was accompanied by loss
of specificity for substrate. Therefore, we have tested the
specificity of the ornithine/citrulline carrier after reaction
with 0.1 mM p-OHMB. For methodological reasons [21],
these experiments were carried out by measuring the uptake
of labeled substances into proteoliposomes without internal
substrate. Furthermore, since pyridoxal 5-phosphate and
NEM were not more effective as stop inhibitors on the
modified protein, we measured the amount of substrate
taken up after 30 min. The results in Table 2 clearly
demonstrate that the substrate specificity of the ornithine/
citrulline carrier was significantly reduced after treatment
with mercurials. The carrier, which in the unmodified
condition catalysed unidirectional transport of only orni-
thine, lysine and arginine (see also Ref. [18]), after reaction
with p-OHMB, catalysed transport of glutamine, choline, 2-
oxoglutarate, malate and carnitine. ATP, citrate and sucrose
were not transported by the modified carrier. In control
experiments, it was tested that the specificity of the protein
was restored after the addition of DTE to proteoliposomes
preincubated with p-OHMB (experiments not shown). To
achieve the same effect of 100 AM p-OHMB, 150 AM p-
CMBS or 1 mM HgCl2 was required. NEM, DTNB and
MTS compounds were ineffective (not shown).
3.3. Differentiation of SH group populations
We have investigated whether the inhibition of the
physiological transport (ornithine/ornithine and ornithine/
H+ transport modes) and the induction of the pore-like
activity can be correlated to different classes of SH groups
of the carrier protein. To this aim, NEM, which reacts
irreversibly with the carrier and does not induce uniport,
was first added to proteoliposomes, thus blocking physio-
logical activity in ornithine-loaded vesicles (Fig. 4); p-
OHMB, subsequently added to the same pool of proteoli-
posomes, was still able to induce efflux of ornithine. The
following addition (45 min) of DTE stopped the mercurial
induced efflux, i.e. although the effect of p-OHMB was
abolished, the previous inhibition by NEM was still
retained. Thus, the effect of p-OHMB is reversible and the
two reagents interact with different SH groups. In agree-
ment, the addition of DTE after incubation of the proteoli-
posomes with p-OHMB slowed down the efflux at a rate
overlapping that of the ornithine/H+ transport mode. Further
addition of external ornithine stimulated again the efflux by
inducing the ornithine/ornithine antiport. The data described
indicate the existence of at least two different SH group
populations involved in the inhibition of the physiological
transport modes or in the induction of the pore-like activity,
respectively.
In order to verify whether different SH groups of the
protein may be in close proximity, we have tested the
influence of S–S forming reagents on the activity of the
ornithine/citrulline carrier. The incubation of proteolipo-
somes with 20 AM Cu2 +-phenanthroline for 2 min resulted
in less than 20% inhibition of the ornithine/citrulline carrier.
Thus, we studied the time dependence of the inhibition on
the ornithine/ornithine antiport measured as uptake of
labeled ornithine into reconstituted proteoliposomes. As
Table 2
Substrate specificity of the unidirectional transport catalysed by the
reconstituted ornithine/citrulline carrier in the presence and absence of p-
OHMB
Substrate Activity (mmol/30 min/g protein)
 p-OHMB + p-OHMB
Ornithine (liposomes) 0.01F 0.01 0.02F 0.01
Ornithine (proteoliposomes,
boiled carrier)
0.02F 0.01 0.02F 0.02
Ornithine 0.23F 0.06 0.31F 0.07
Citrulline 0.02F 0.01 0.45F 0.20
Lysine 0.16F 0.06 0.39F 0.06
Arginine 0.20F 0.06 0.40F 0.08
Carnitine 0.04F 0.11 0.28F 0.06
Glutamine 0.06F 0.03 0.30F 0.15
Choline 0.01F 0.01 0.28F 0.06
Malate 0.01F 0.01 0.16F 0.12
ATP n.d. n.d.
Citrate n.d. n.d.
2-Oxoglutarate n.d. 0.54F 0.20
Sucrose n.d. 0.05F 0.05
Each of the indicated substrates (0.1 mM) was added in radioactive form to
proteoliposomes without internal substrate, in the presence or absence of
0.1 mM p-OHMB. After 30-min incubation, the reaction was stopped by
passing the samples through cold (0 jC) Sephadex G-50 columns within 1
min as described in Materials and methods. The controls were performed by
adding labeled ornithine to liposomes or to proteoliposomes reconstituted
with boiled carrier protein.
The values are meansF S.D. for three experiments; n.d., not detectable.
Fig. 4. Induction by p-OHMB of [3H]ornithine efflux from proteoliposomes
preincubated with NEM and subsequent effect of DTE. Efflux of 30 mM
[3H]ornithine from prelabeled proteoliposomes was monitored as described
in Materials and methods, in the presence of external 10 mM HEPES pH
8.0, 60 mM sucrose (ornithine/H+ exchange). Additions were the following:
(o) control, no additions; (.) 0.1 mM p-OHMB; (D) 1 mM NEM 1 min
before the start, 0.1 mM p-OHMB at 30 min and 2 mM DTE at 45 min; (5)
0.1 mM p-OHMB at the start, 2 mM DTE at 5 min and 10 mM ornithine at
30 min. Similar results were obtained in four different experiments.
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shown by Fig. 5, the activity decreased with the incubation
time being close to zero after 40-min incubation with the
reagent. The activity was reversed by the addition of DTE,
with a time dependence not very different from that of
inactivation. Complete recovery of activity was achieved
about 60 min after the addition of the reducing reagent.
After this time, about 110% activity (with respect to the
initial situation) was recovered, indicating that a fraction of
about 10% of the carrier was spontaneously oxidized before
reconstitution (see also Table 1). Therefore, it is clear that at
least two SH groups are in close proximity to form an S–S
bridge and that the oxidized protein is not active. A similar
time dependence of inhibition was observed with diamide
(not shown). Samples treated neither with Cu2 +-phenanthro-
line nor with DTE showed no appreciable variation of
activity within 100 min.
Now a further question arises, whether these groups
correspond to those reacting with NEM or p-OHMB. To
answer this question, we performed the experiment of Fig.
6. Proteoliposomes pretreated with Cu2 +-phenanthroline,
under conditions leading maximal inhibition of the carrier,
were then used to follow the efflux of labeled ornithine. The
negligible efflux in the absence (ornithine/H+ transport
mode,  ) or presence (ornithine/ornithine transport mode,
o) of external ornithine, with respect to the control (pro-
teoliposomes not pretreated with Cu2 +-phenanthroline),
confirmed that pretreatment with Cu2 +-phenanthroline lead
to inhibition of both the transport modes catalysed by the
ornthine/citrulline carrier. The addition of 0.1 mM p-OHMB
to the Cu2 +-phenanthroline-treated protein determined a fast
efflux of [3H]ornithine, indicating that the SH group(s)
reacting with the mercurial reagent (at high concentration)
is different from those forming S–S bridge(s). To verify
whether SH groups reacting with NEM (MTS and mercu-
rials at low concentration) were involved in the S–S bridge
formation, DTE, as an S–S reducing agent, has been used.
As shown by Fig. 6, DTE restored the activity of the carrier
pretreated with Cu2 +-phenanthroline, but not that of the
carrier treated with Cu2 +-phenanthroline and then by NEM.
This indicated that NEM also irreversibly bound to the
oxidized protein, i.e. in the presence of S–S bridge(s).
Therefore, the SH group population reacting with NEM is
different from that involved in the S–S formation. Over-
lapping results were obtained by using diamide instead of
Cu2 +-phenanthroline (not shown).
4. Discussion
In order to gain information on the role of SH groups in
the transport activity of the mitochondrial ornithine/citrul-
line carrier, we have carried out a detailed characterization
of the effect of several SH reagents on the two transport
modes catalysed by the reconstituted carrier.
The substrate antiport, monitored as [3H]ornithine uptake
into proteoliposomes containing unlabeled ornithine, was
Fig. 6. Inhibition of [3H]ornithine efflux from proteoliposomes by Cu2 +-
phenanthroline and effect of NEM. Efflux of 30 mM [3H]ornithine from
prelabeled proteoliposomes was measured as described in Materials and
methods, except that an aliquot of prelabeled proteoliposomes was
incubated with 20 AM Cu2 +-phenanthroline for 30 min (D, o, E, .
and ) before the passage through the second Sephadex G-75 (see
Materials and methods). In the samples preincubated with Cu2 +-
phenanthroline, the additions were the following: ( ) none (buffer alone:
10 mM HEPES pH 8.0, 60 mM sucrose); (o) 10 mM external ornithine (in
a buffer containing 10 mM HEPES pH 8.0, 40 mM sucrose); (.) 10 mM
external ornithine plus 10 mM DTE; (D) 1 mM NEM 1 min before the start
and 10 mM DTE plus 10 mM ornithine at the start; (E) 0.1 mM p-OHMB.
In the samples not preincubated with Cu2 +-phenanthroline, the additions
were the following: (5) 10 mM external ornithine; (z) 1 mM NEM 1 min
before the start and 10 mM DTE plus 10 mM external ornithine at the start.
Similar results were obtained in four different experiments.
Fig. 5. Time dependence of the inhibition of the ornithine/ornithine antiport
by Cu2 +-phenanthroline and effect of DTE. Proteoliposomes containing 30
mM ornithine were incubated with 20 AM Cu2 +-phenanthroline, and after
40 min, 2 mM DTE was added. At the indicated times, aliquots of
proteoliposomes were used for transport assay. Ornithine/ornithine antiport
was measured by adding 0.1 mM [3H]ornithine and stopped after 10 min, as
described in Materials and methods. Percent residual activity with respect to
the control are reported. The control activity (ornithine/ornithine antiport
before incubations) was 1.92F 0.50 mmol/10 min/g protein; the values are
meansF S.D. from three experiments.
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strongly inhibited by several compounds with different
efficiency. Thus, there is an SH population responsible for
the inhibition of the transport activity. The difference in IC50
among inhibitors of the same type may be due to different
interaction of side groups of the reagents with specific
hydrophilic/hydrophobic residues of the protein. In this
respect, the differences among the reagents belonging to
the MTS group [28,29] may give some information about
the environment in which the SH group responsible of the
transport inhibition is located. The finding that the posi-
tively charged MTSEA and MTSET show higher affinity for
the carrier (lower IC50) than the negatively charged MTSES
suggest that the Cys involved in the binding with the
reagents is located in an hydrophilic environment, close to
an acidic residue (Glu or Asp). Furthermore, since the SH
group readily reacts with the membrane-impermeable
reagents p-CMBS, MTSET and MTSES, it is expected to
be exposed to the extraliposomal face of the carrier that
corresponds, as previously reported [15], to the cytosolic
side. By experiments based on competition among the
various reagents, we found that reversible SH reagents
prevent binding of NEM to the protein; however, a fraction
of the protein ranging from about 20% to 50% can still be
derivatized by NEM even after treatment with MTSEA,
DTNB or mercurials. These data indicate that the reagents
interact mostly with the same SH group. The residual
availability of SH for NEM binding, in the presence of
the reversible reagents, may be explained by the presence of
(at least) two SH groups: the first SH with higher affinity for
the reagents, the second with lower affinity. The reagent
added before binds completely to the high-affinity SH
leading to total inactivation of the protein and it binds only
partially to the second SH; thus, a fraction of the protein
(depending on the affinity of the reagent added before, for
the second SH) is available for the reaction with NEM. On
the basis of these considerations, the SH group population
related with the transport inhibition should be constituted by
more than one Cys residue.
The second mode of action, i.e. the ornithine/H+ trans-
port mode, measured as the efflux of [3H]ornithine from
proteoliposomes, was inhibited by NEM, MTSEA, DTNB
and mercurial reagents at low concentrations ( < 5 AM). At
higher concentrations, p-OHMB and p-CMBS induced an
increase of the efflux that masked the inhibition. We
explained the experimental results of Figs. 2 and 3 and
Table 2 as a transition of the activity from a carrier
(ornithine/ornithine and ornithine/H+ transport modes) to a
pore-like function, characterized by loss of specificity for
substrate. This transition of transport function was previ-
ously described for other mitochondrial carriers as induced
by modification of Cys residues [19–22,30], deletion of
specific amino acid sequences [31] or treatment with Ca2 +
[32]. The pore-like transport function of the ornithine/citrul-
line carrier, similarly to the aspartate/glutamate, carnitine
and phosphate carriers [19–22], was induced by mercurials
and it was reverted by DTE. Since p-OHMB, instead of
HgCl2 [19–22], was the most effective inducing reagent in
the case of the ornithine/citrulline carrier, a different envi-
ronment of the active SH group of this carrier with respect
to the others is expected. A peculiar property of the
ornithine/citrulline carrier upon transition is the increase in
the transport rate with respect to the unmodified protein. A
possible physiopathological implication of the switch of this
carrier to the pore-like function will be matter of further
investigation. It should be mentioned that the conversion of
the ADP/ATP carrier to a pore has been found to be related
with programmed cell death [33–35].
An additional effect, related to Cys residues of the
carrier, has been found upon treatment with SH-oxidizing
reagents. Experiments performed with Cu2 + phenanthroline
demonstrate the presence of at least two close SH groups
that may form an S–S bridge leading to inactivation of the
protein. This probably indicates that the domain(s) of the
protein, in which these SH are located, is involved in
conformational changes leading to the substrate permeation
through the membrane. The cross-link of two Cys residues,
which lead to higher degree of rigidity, inhibits the transport
activity. The oxidation reaction, leading to the S–S bridge
formation, seems to be at least one order of magnitude
slower than the reaction of the protein with the other
reagents (NEM, MTS, mercurials and DTNB); this may
be explained by a low accessibility of the S–S forming Cys,
i.e. a location of these residues either in the transmembrane
region or on the intraliposomal (matrix [15]) side of the
protein.
The effects induced by the different SH reagents: (i) the
inhibition of physiological transport modes (substrate anti-
port and ornithine/H+ transport mode) due to the modifica-
tion of SH residues, (ii) the induction of the pore-like
activity by mercurials and (iii) the inhibition of physiolog-
ical transport modes due to S–S formation unraveled the
existence of three functionally different SH group popula-
tions in the protein. This is a peculiar aspect of the ornithine/
citrulline carrier, and it is in agreement with the finding that
both the human and the mouse ornithine carrier sequences
[10] contain nine Cys, the highest number of Cys residues of
functionally known mitochondrial carriers [for a database of
mitochondrial carrier sequences, see http://drnelson.utmem.
edu/nelsonhomepage.html]. Moreover, the first and the third
Cys populations are constituted by at least two residues
each, with those of the third population close enough to
form S–S bridge. Thus, the ornithine/citrulline carrier
possesses at least five independent SH groups involved in
the modifications of the activity, some of them being
potential sites of regulation of the carrier function.
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